Originally published byEU-Startups
CriteriaCaixa, the Barcelona-based holding company that manages the business assets of ‘la Caixa’ Banking Foundation, today announces a reboot of its startup investment business to facilitate the growth of science and technology-based high-potential emerging companies. Through its two funds, Criteria Bio Ventures and Criteria Venture Tech, it plans to invest €300 million ($343 million) in […]
The post €300 million for Iberian BioTech and DeepTech as CriteriaCaixa rebrands its VC arm appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
'If you're not AI-native, you're not getting funded': European fintech's H1 funding figures
14h ago
Inside Mistral’s monster fundraise and Palantir-like repositioning
11h ago
AI music platform Suno hits bum note as 55M users exposed in data breach, claims infosec expert
11h ago
New Unicorn! Humanoid secures €133 million at €1.1 billion valuation to scale industrial robotics and physical AI
10h ago
Why Europe doesn’t need another Silicon Valley to succeed
10h ago